Brief: Acorda Therapeutics Announces Nasdaq Delisting Notification
03/04/2024 22:44
April 3 (Reuters) - Acorda Therapeutics Inc ACOR.O :
* ACORDA THERAPEUTICS ANNOUNCES NASDAQ DELISTING
NOTIFICATION
* ACORDA THERAPEUTICS INC - NASDAQ NOTIFIED CO IT WILL
SUSPEND
TRADING IN AND DELIST CO'S COMMON STOCK, EFFECTIVE ON APRIL 12,
2024
* ACORDA THERAPEUTICS INC - ONCE DELISTING TAKES EFFECT,
ACORDA
EXPECTS ITS COMMON STOCK TO BEGIN TRADING ON PINK OPEN MARKET
Source text for Eikon: ID:nBw7RLvGFa
Further company coverage: ACOR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acorda Therapeutics
See all newsBrief: Acorda TherapeuticsCourt Held Hearing To Consider Approval Of Sale Of Substantially All Of Co's Assets To Merz Pharmaceuticals Under Asset Sale
Brief: Acorda Says Debtors Did Not Receive More Than One Qualified Bid Before Bid Deadline, In Connection With Chapter 11 Proceedings
Live Markets: Biotech companies in 'Darwinian' world as cash remains king
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease (updated)
U.S. FDA declines to approve Supernus' drug-device combination for Parkinson's disease